(Press-News.org) A new cancer vaccine could boost the positive effects of existing immunotherapy drugs, improving the success rate of treatments from 20% to 75% of cases, according to a new study by immunologists from the University of Konstanz. The vaccine, which incorporates a new immunostimulant that is safe for use in humans, was shown to partially eliminate tumours in mice. However, the study further demonstrated that combining the vaccine with an immune checkpoint inhibitor -- an established immunotherapy drug with a 20% success rate overall for patients -- can vastly improve the proportion of individuals who respond to treatments, eliminating tumours in 75% of cases in mice. The results suggest that this new approach of using a vaccine in combination with established drugs may be a potent anti-cancer immunotherapy to be tested in future clinical trials. The findings appeared in Nature Communications on May 18, 2021.
Cancer therapy has seen a major breakthrough in recent years due to a type of immunotherapy known as "immune checkpoint inhibition". Immune checkpoint inhibitors work by stopping the body's natural ramping down of its immune response, causing the body instead to sustain its attack on tumour cells. This has proven to be effective for certain types of cancers, such as melanoma and squamous cell skin cancer, lung cancer, kidney cancer, and liver cancer.
But not all cancer patients respond to this immunotherapy. For example, only 20% of patients with melanoma can be cured. An explanation for why many do not respond well is that immune checkpoint inhibitors rely on the body initiating an immune response, which the drugs then prolong. If the body does not recognise its tumour cells as foreign, the immune checkpoint inhibitors have no immune cells to work off.
Now, a team led by Professor Marcus Groettrup, Chair of Immunology at the University of Konstanz, has developed a technique that kickstarts an immune response to a tumour. The microparticle-based cancer vaccine, which uses the immunostimulant Riboxxim that has the approval for application in humans, can generate the body's T-cell response that is necessary for immune checkpoint blockade drugs to be effective.
"A major shortcoming in cancer vaccines is the availability of immunostimulants that can be used in humans," says Marcus Groettrup, senior author on the study. "We can show that our clinically applicable vaccine combined with immune checkpoint blockade leads to an increase in the proportion of mice that can be cured of existing tumours to 75 percent."
A cancer vaccine that's safe for humans
The aim of the study was to develop a particle-based cancer vaccine which effectively launches an immune response against tumours and that is suitable for transition into clinical application.
The team created particles measuring 1 micrometre (or 0.001 mm) that included a tumour protein and Riboxxim--a molecule that primes the immune system to launch a response. Riboxxim is produced by the company Riboxx Pharmaceuticals in Dresden, Germany.
Mice that were injected with a single dose of the microparticle-based vaccine launched a strong anti-tumour immune response that was still detectable after 8 weeks. Even very low doses of the vaccine were able to generate strong immune responses compared to other immunostimulants.
The team tested the vaccine against a range of fragments from cancer proteins, including those of prostate cancer, breast cancer, and melanoma. Strong cellular immune responses against all these antigen fragments were obtained in mice, suggesting that the new approach might be applied to a variety of cancers.
A synergistic combination
However, due to the body's natural down regulation of its immune response, the tumours gradually returned 30 days after vaccination. But if the vaccine was combined with an immune checkpoint inhibitor, the therapeutic benefits continued and tumours were eliminated.
"We were able to formulate a clinically applicable cancer immunotherapy which acts complementary to commonly used immunotherapy," says Dennis Horvath, who is joint-first author on the study together with Julia Koerner. Horvath is a doctoral student at the Cluster of Excellence 'Centre for the Advanced Study of Collective Behaviour' at the University of Konstanz (CASCB). He also uses this vaccination approach to study the effect of social stress on the immune response in mice, testing whether immunosuppression by stress will limit the therapeutic success of immunotherapy.
Based on the study's findings, the researchers suggest that these promising pre-clinical results should be transitioned into clinical application. "This might have a very beneficial impact on immunotherapy in certain types of cancer," says Groettrup.
The therapeutic concept developed in this study is currently being tested in a first small phase 1 clinical trial by project partners in the Netherlands to find out if it is similarly effective in humans.
INFORMATION:
Facts:
* Original publication: J. Koerner, D. Horvath, V. L. Herrmann, A. MacKerracher, B. Gander, H. Yagita, J. Rohayem & M. Groettrup (2021) "PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy". Nature Communications. DOI: 10.1038/s41467-021-23244-3.
* A particle-based vaccine against tumours containing the novel immunostimulant Riboxxim has been developed.
* The vaccine containing a tumour protein and Riboxxim can eliminate tumours in mice.
* The combination of the vaccine with immune checkpoint blockade strongly improves the success of tumour immunotherapy.
* The project was funded by the EU international project 'PRECIOUS' and by the Cluster of Excellence 'Centre for the Advanced Study of Collective Behaviour' at the University of Konstanz.
Climate change induced yield reductions can be compensated by cultivar adaptation and global production can even be increased.
Global agriculture both is one of the major drivers of climate change and strongly affected by it. Rising temperatures are among the main reasons for yield reductions. Therefore, the agricultural sector is faced with the major challenge of adapting to climate change in order to ensure food security in the future. According to a new study carried out by international researchers, the use of locally adapted cultivars can significantly contribute to achieve this goal. The study ...
(Boston)--Researchers from Boston University School of Medicine (BUSM) report the formation of human cells containing a green fluorescent protein or GFP (one of the most important proteins in biology and fluorescence imaging) genetically fused with two interferon stimulated genes (ISGs), namely Viperin and ISG15. This new creation makes these cells highly valuable reagents for reporting innate immune responses to viral infections, including those caused by coronaviruses.
These engineered cells, which turn green when treated with interferon, are highly novel because this is the first time a reporter gene (a gene ...
A filter made from polymer nanothreads blew three kinds of commercial masks out of the water by capturing 99.9% of coronavirus aerosols in an experiment.
"Our work is the first study to use coronavirus aerosols for evaluating filtration efficiency of face masks and air filters," said corresponding author Yun Shen, a UC Riverside assistant professor of chemical and environmental engineering. "Previous studies have used surrogates of saline solution, polystyrene beads, and bacteriophages -- a group of viruses that infect bacteria."
The study, led by engineers at UC Riverside and The George Washington University, compared ...
The wild relatives of modern peanut plants have the ability to withstand disease in ways that peanut plants can't. The genetic diversity of these wild relatives means that they can shrug off the diseases that kill farmers' peanut crops, but they also produce tiny nuts that are difficult to harvest because they burrow deep in the soil.
Consider it a genetic trade-off: During its evolution, the modern peanut lost its genetic diversity and much of the ability to fight off fungus and viruses, but gained qualities that make peanut so affordable, sustainable and tasty that people all over the world grow and eat them.
Modern peanut plants were created 5,000 to ...
OAK BROOK, Ill. - An artificial intelligence (AI) program accurately predicts the risk that lung nodules detected on screening CT will become cancerous, according to a study published in the journal Radiology.
Lung cancer is the leading cause of cancer death worldwide, with an estimated 1.8 million deaths in 2020, according to the World Health Organization. Low-dose chest CT is used to screen people at a high risk of lung cancer, such as longtime smokers. It has been shown to significantly reduce lung cancer mortality, primarily by helping to detect cancers at an early stage when they are easier to treat successfully.
While lung cancer typically shows up as pulmonary nodules on CT images, most nodules are benign ...
Researchers have identified specific influenza targets that could be used to better protect Indigenous people from experiencing severe influenza disease through a universal, T cell-based vaccine.
In a collaboration with Monash Biomedicine Discovery Institute, Menzies School of Health Research and CQUniversity, Peter Doherty Institute for Infection and Immunity (Doherty Institute) researchers took a deep-dive look into how the immune system can protect Aboriginal and Torres Strait Islander people from severe influenza disease.
"We know that some populations are at high risk from severe influenza, and these include Indigenous people ...
Fields of opium poppies once bloomed where the Zurich Opera House underground garage now stands. Through a new analysis of archaeological seeds, researchers at the University of Basel have been able to bolster the hypothesis that prehistoric farmers throughout the Alps participated in domesticating the opium poppy.
Although known today primarily as the source of opium and opiates, the poppy is also a valuable food and medicinal plant. Its seeds can be used to make porridge and cooking oil. Unlike all other previously domesticated crops, which are assumed to ...
The research team, led by Academician GUO Guangcan from University of Science and Technology of China (USTC) of the Chinese Academy of Sciences, collaborating with LI Bo from Shangrao Normal University and CHEN Jingling from Nankai University, achieved the masking of optical quantum information. The researchers concealed quantum information into non-local quantum entangled states. The study was published in the journal Physical Review Letters.
Quantum information masking as one of the new information processing protocol transfers quantum information from a single quantum carrier to the quantum entangled state between multiple carriers avoiding the information ...
Fossils of land animals from South America have been found in the Antilles, but how did these animals get there? According to scientists from the CNRS, l'Université des Antilles, l'Université de Montpellier and d'Université Côte d'Azur, land emerged in this region and then disappeared beneath the waves for millions of years, explaining how some species were able to migrate to the Antilles. This study will be published in June 2021 issue in Earth-Science Reviews.
Fossils of land animals from the Antilles, including mammals and amphibians, have their closest relatives in South America. The crossing of the Caribbean Sea from South America was therefore possible, but how?
As swimming across the continent ...
Urban megaprojects tend to be the antithesis of good urban planning. They have a negative impact on local water systems, deprive local communities of water-related human rights, and their funders and sponsors have little accountability for their impact.
These are the findings of the University of Adelaide's Dr Scott Hawken from the School of Architecture and Built Environment who led a review of the impact of urban megaprojects on water justice in South East Asia.
"Urban megaprojects have severe implications for environmental processes," said Dr Hawken.
"They have a major impact on hydrological systems and during all phases of development affect water security and human ...
